Renee L Mauer, CRNA | |
3901 Rainbow Blvd, Kansas City, KS 66160-8500 | |
(913) 588-6670 | |
(913) 588-3365 |
Full Name | Renee L Mauer |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 41 Years |
Location | 3901 Rainbow Blvd, Kansas City, Kansas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033207345 | NPI | - | NPPES |
913713673 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 108046 (Kansas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Anesthesia Associates Of Kansas City Pa | 1951206168 | 222 |
News Archive
Lawmakers in both chambers are calling for Congress to start a conversation about mental health issues in the wake of last week's deadly shooting at a Connecticut elementary school, with one goal of ensuring adequate funding for services for those who need treatment.
MPM Capital and Atlas Venture announced today that portfolio company CoStim Pharmaceuticals, Inc. has been acquired by Novartis for an undisclosed amount. CoStim, founded in 2012 by MPM Managing Director Luke Evnin together with MPM Managing Director-Operations Robert Millman, is an emerging immuno-oncology company developing monoclonal antibody drugs that enable a patient's own immune system to better fight cancer.
A study published in the Aug. 4, 2010 issue of the Journal of Neuroscience introduces an enzyme that could pack a big punch in the battle against chronic pain. Its name is prostatic acid phosphatase or PAP for short. According to researchers at the University of North Carolina at Chapel Hill, PAP blocks pain in animal models by siphoning off a molecule called PIP2—a critical component of the chemical cascade behind chronic pain.
Some 25 percent of breast cancer surgery patients experience significant, persistent pain six months after the procedure, and new research published in The Journal of Pain showed that women with preoperative breast pain have the highest risk for extended post-surgical pain.
› Verified 9 days ago
Entity Name | Anesthesia Associates Of Kansas City Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174504732 PECOS PAC ID: 1951206168 Enrollment ID: O20050721001069 |
News Archive
Lawmakers in both chambers are calling for Congress to start a conversation about mental health issues in the wake of last week's deadly shooting at a Connecticut elementary school, with one goal of ensuring adequate funding for services for those who need treatment.
MPM Capital and Atlas Venture announced today that portfolio company CoStim Pharmaceuticals, Inc. has been acquired by Novartis for an undisclosed amount. CoStim, founded in 2012 by MPM Managing Director Luke Evnin together with MPM Managing Director-Operations Robert Millman, is an emerging immuno-oncology company developing monoclonal antibody drugs that enable a patient's own immune system to better fight cancer.
A study published in the Aug. 4, 2010 issue of the Journal of Neuroscience introduces an enzyme that could pack a big punch in the battle against chronic pain. Its name is prostatic acid phosphatase or PAP for short. According to researchers at the University of North Carolina at Chapel Hill, PAP blocks pain in animal models by siphoning off a molecule called PIP2—a critical component of the chemical cascade behind chronic pain.
Some 25 percent of breast cancer surgery patients experience significant, persistent pain six months after the procedure, and new research published in The Journal of Pain showed that women with preoperative breast pain have the highest risk for extended post-surgical pain.
› Verified 9 days ago
Entity Name | Orthomed Staffing Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225514276 PECOS PAC ID: 9638429178 Enrollment ID: O20230929001116 |
News Archive
Lawmakers in both chambers are calling for Congress to start a conversation about mental health issues in the wake of last week's deadly shooting at a Connecticut elementary school, with one goal of ensuring adequate funding for services for those who need treatment.
MPM Capital and Atlas Venture announced today that portfolio company CoStim Pharmaceuticals, Inc. has been acquired by Novartis for an undisclosed amount. CoStim, founded in 2012 by MPM Managing Director Luke Evnin together with MPM Managing Director-Operations Robert Millman, is an emerging immuno-oncology company developing monoclonal antibody drugs that enable a patient's own immune system to better fight cancer.
A study published in the Aug. 4, 2010 issue of the Journal of Neuroscience introduces an enzyme that could pack a big punch in the battle against chronic pain. Its name is prostatic acid phosphatase or PAP for short. According to researchers at the University of North Carolina at Chapel Hill, PAP blocks pain in animal models by siphoning off a molecule called PIP2—a critical component of the chemical cascade behind chronic pain.
Some 25 percent of breast cancer surgery patients experience significant, persistent pain six months after the procedure, and new research published in The Journal of Pain showed that women with preoperative breast pain have the highest risk for extended post-surgical pain.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Renee L Mauer, CRNA Po Box 411851, Kansas City, MO 64141-1851 Ph: (913) 588-6670 | Renee L Mauer, CRNA 3901 Rainbow Blvd, Kansas City, KS 66160-8500 Ph: (913) 588-6670 |
News Archive
Lawmakers in both chambers are calling for Congress to start a conversation about mental health issues in the wake of last week's deadly shooting at a Connecticut elementary school, with one goal of ensuring adequate funding for services for those who need treatment.
MPM Capital and Atlas Venture announced today that portfolio company CoStim Pharmaceuticals, Inc. has been acquired by Novartis for an undisclosed amount. CoStim, founded in 2012 by MPM Managing Director Luke Evnin together with MPM Managing Director-Operations Robert Millman, is an emerging immuno-oncology company developing monoclonal antibody drugs that enable a patient's own immune system to better fight cancer.
A study published in the Aug. 4, 2010 issue of the Journal of Neuroscience introduces an enzyme that could pack a big punch in the battle against chronic pain. Its name is prostatic acid phosphatase or PAP for short. According to researchers at the University of North Carolina at Chapel Hill, PAP blocks pain in animal models by siphoning off a molecule called PIP2—a critical component of the chemical cascade behind chronic pain.
Some 25 percent of breast cancer surgery patients experience significant, persistent pain six months after the procedure, and new research published in The Journal of Pain showed that women with preoperative breast pain have the highest risk for extended post-surgical pain.
› Verified 9 days ago
Mrs. Michelle Renee Altenhofen, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5000 | |
Nicki L Hamilton, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6670 Fax: 212-263-0664 | |
Morgan Bassi, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5000 | |
Kami Lynn Craigg, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-588-1227 | |
John Wade Fogarty, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-588-1200 | |
Trevor Mason, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-424-2635 |